期刊文献+

青岛地区鲍曼不动杆菌的临床分布及耐药性分析

ACINETOBACTER BAUMANII: ITS CLINICAL DISTRIBUTION AND DRUG RESISTANCE IN QINGDAO AREAS
在线阅读 下载PDF
导出
摘要 ①目的 了解青岛地区鲍曼不动杆菌的临床分布特点及耐药性趋势 ,指导临床合理使用抗菌药物。②方法 采用MicroscanMA 4 0全自动细菌鉴定系统或API系统对本地区临床标本进行鲍曼不动杆菌分离培养并使用K B法检测其耐药性。③结果 共分离鲍曼不动杆菌 6 2 6株 ,主要来源于呼吸内科 (36 .9% )和ICU病房(31.0 % ) ,其次为神经内科病房 (12 .1% )、肿瘤科病房 (11.0 % )和其他病房 (8.9% ) ;该菌广泛耐药 ,除对亚胺培南、特治星等少数抗菌药物敏感外 ,对临床常用抗菌药物的耐药率较高。④结论 鲍曼不动杆菌是呼吸内科和ICU病房医院感染的主要病原菌 ,且对常用抗菌药物呈现多重耐药 。 Objective To investigate the clinical distribution and drug resistance of pathogenic Acinetobacter baumanii so as to guide a proper use of antibiotics. Methods An identification of Acinetobacter baumanii strains was done by Microscan MA-40 bactera analysis system and /or API system. Drug resistance was analyzed by K-B method. Results Acinetobacter baumanii was isolated in 626 strains. They were mainly found in wards of respiratory diseases (36.9%) and intensive care units (31.0%). They were also seen in wards of neurology (12.1%), oncology (11.0%), and others (8.9%). These strains were highly resistant to most commonly-used antibiotics, sensitive only to imipenem(IMP). Conclusion Acinetobacter baumanii is commonly seen in nosocomial infection, and seriously resistant to a wide range of antibiotics. A great attention should be paid to it.
出处 《齐鲁医学杂志》 2003年第4期408-409,共2页 Medical Journal of Qilu
  • 相关文献

参考文献5

  • 1陈敏,张再伟,尹维佳,韩素梅,刘自贵,雷秉钧,徐世兰.医院下呼吸道不动杆菌感染的危险因素及耐药性[J].中国抗感染化疗杂志,2001,1(3):169-170. 被引量:10
  • 2张军民,吴坚,陈民钧,王清涛,张秀珍,张淑兰.鲍氏不动杆菌5年耐药性监测结果分析[J].中华医学检验杂志,1999,22(1):51-53. 被引量:121
  • 3Cisneros JM , Reyes MT , Pachon T ,et al. Bacteremia due to Acinetobacter baumannii: epidemiology, clinical findings, and prognostic features[J]. Clin Infect Dis, 1996,22:1026.
  • 4Seerpella EG, Wanger AR, Armitige L, et al. Noseomial outbreak caused by a multiresistant clone of Acinetobacter baumannii: results of the case-control and epidemiologic investigations [J]. Infect Control Hosp Epidemiol, 1995,16 (2) : 92.
  • 5Vila J, Marcos A , Marco F, et al. In vitro centimicrobial production of β-lactamases, aminoglycoside-modifying enzymes,and chloramphenicol acetyltransferase by and susceptibility of clinical isolates of Acinetobacter baumanii [J]. Antimicrob Agents Chemather,1993,37:138.

二级参考文献7

共引文献129

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部